118 related articles for article (PubMed ID: 9217626)
1. Estrogen-induced pancreatitis after discontinuation of concomitant medroxyprogesterone therapy.
Isley WL; Oki J
Am J Med; 1997 Apr; 102(4):416-7. PubMed ID: 9217626
[No Abstract] [Full Text] [Related]
2. [Treatment with estrogen].
Ingelman-Sundberg A
Lakartidningen; 2002 Nov; 99(47):4777-8. PubMed ID: 12523062
[No Abstract] [Full Text] [Related]
3. HRT: forever or never?
Corson SL
Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
[No Abstract] [Full Text] [Related]
4. Effect of continuous administration of conjugated estrogen plus medroxyprogesterone acetate (Premelle) in postmenopausal women in Taiwan.
Yang TS; Wang HL; Chen YJ; Chang SP; Yuan CC
J Chin Med Assoc; 2004 Jul; 67(7):336-43. PubMed ID: 15510930
[TBL] [Abstract][Full Text] [Related]
5. Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study.
Ausmanas MK; Holinka CF; Ling YS; Christiansen C
Climacteric; 2007 Aug; 10(4):306-13. PubMed ID: 17653957
[TBL] [Abstract][Full Text] [Related]
6. Progesterone and Synthetic Progestin Controversies.
Gompel A; Plu-Bureau G
JAMA Oncol; 2015 Oct; 1(7):987. PubMed ID: 26448287
[No Abstract] [Full Text] [Related]
7. Progesterone and Synthetic Progestin Controversies.
Jordan VC; Maximov PY; Fan P
JAMA Oncol; 2015 Oct; 1(7):986-7. PubMed ID: 26448286
[No Abstract] [Full Text] [Related]
8. Progesterone and Synthetic Progestin Controversies--Reply.
Joshi PA; Goodwin PJ; Khokha R
JAMA Oncol; 2015 Oct; 1(7):987-8. PubMed ID: 26448288
[No Abstract] [Full Text] [Related]
9. Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group.
Woodruff JD; Pickar JH
Am J Obstet Gynecol; 1994 May; 170(5 Pt 1):1213-23. PubMed ID: 8178840
[TBL] [Abstract][Full Text] [Related]
10. Importance of the progestogen added to the estrogen in hormone therapy.
Lauritzen C
Climacteric; 2005 Dec; 8(4):398-400. PubMed ID: 16390775
[No Abstract] [Full Text] [Related]
11. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
Osmanağaoğlu MA; Osmanağaoğlu S; Osmanağaoğlu T; Okumuş B; Bozkaya H
Fertil Steril; 2005 Aug; 84(2):384-93. PubMed ID: 16084879
[TBL] [Abstract][Full Text] [Related]
12. Do estrogen effects on blood vessels translate into clinically significant atheroprotection?
Pradhan S; Sumpio BE
J Am Coll Surg; 2004 Mar; 198(3):462-74. PubMed ID: 14992749
[No Abstract] [Full Text] [Related]
13. Summaries for patients: The effect of estrogen plus progestin on coronary heart disease.
Ann Intern Med; 2010 Feb; 152(4):I-40. PubMed ID: 20157120
[No Abstract] [Full Text] [Related]
14. Hormone therapy in younger women and cognitive health.
Grodstein F
JAMA Intern Med; 2013 Aug; 173(15):1437-8. PubMed ID: 23797264
[No Abstract] [Full Text] [Related]
15. Management of menopause-related symptoms.
Danby FW
Ann Intern Med; 2005 Dec; 143(11):845-6; author reply 846. PubMed ID: 16330803
[No Abstract] [Full Text] [Related]
16. What pharmacists need to know about the women's health initiative estrogen plus progestin trial.
Saseen JJ; Hansen LB
Am J Health Syst Pharm; 2003 Feb; 60(3):281-4. PubMed ID: 12613239
[No Abstract] [Full Text] [Related]
17. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
Langer RD
Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
[No Abstract] [Full Text] [Related]
18. Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women.
Murkes D; Conner P; Leifland K; Tani E; Beliard A; Lundström E; Söderqvist G
Fertil Steril; 2011 Mar; 95(3):1188-91. PubMed ID: 21067727
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and risk of heart disease.
Elliott KK
Am Fam Physician; 1999 Nov; 60(8):2234, 2237. PubMed ID: 10593314
[No Abstract] [Full Text] [Related]
20. Progesterone Exposure and Breast Cancer Risk: Understanding the Biological Roots.
Joshi PA; Goodwin PJ; Khokha R
JAMA Oncol; 2015 Jun; 1(3):283-5. PubMed ID: 26181171
[No Abstract] [Full Text] [Related]
[Next] [New Search]
